| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0081 | 0.9 |